Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: Results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601-Reference-Cited by-同舟云学术

Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: Results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601

Published:2013-01 Issue:1 Volume:49 Page:90-97
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Ferrand F.,Malka D.,Bourredjem A.,Allonier C.,Bouché O.,Louafi S.,Boige V.,Mousseau M.,Raoul J.L.,Bedenne L.,Leduc B.,Deguiral P.,Faron M.,Pignon J.P.,Ducreux M.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference36 articles.

1. International trends in colorectal cancer incidence rates;Center;Cancer Epidemiol Biomarkers Prev,2009

2. Extending the frontiers of resectability in advanced colorectal cancer;Chun;Eur J Surg Oncol,2007

3. Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients;Ruo;J Am Coll Surg,2003

4. A phase II trial of 5-fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) chemotherapy plus bevacizumab (bev) for patients (pts) with unresectable stage IV colon cancer and a synchronous asymptomatic primary tumor: results of NSABP C-10;McCahill;J Clin Oncol,2010

5. Meta-analysis of survival of patients with stage IV colorectal cancer managed with surgical resection versus chemotherapy alone;Stillwell;World J Surg,2010

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Upfront resection versus no resection of the primary tumor in patients with synchronous metastatic colorectal cancer: the randomized phase III CAIRO4 study conducted by the Dutch Colorectal Cancer Group and the Danish Colorectal Cancer Group;Annals of Oncology;2024-09

2. Survival Benefits of Asymptomatic Primary Tumor Resection After Bevacizumab Plus FOLFIRI as First-Line Therapy for Patients with Metastatic Colorectal Cancer with Synchronous Unresectable Metastasis;2024-07-16

3. The Real-Life Impact of Primary Tumor Resection of Synchronous Metastatic Colorectal Cancer—From a Clinical Oncologic Point of View;Cancers;2024-04-11

4. Clinical Outcomes of Upfront Primary Tumor Resection in Synchronous Unresectable Metastatic Colorectal Cancer;Cancers;2023-10-19

5. The impact of primary tumor resection for asymptomatic colorectal cancer patients with unresectable metastases: a systematic review and meta-analysis;International Journal of Colorectal Disease;2023-08-15